Nanjing Well Pharmaceutical Co Ltd (603351) — Cash Flow-to-Debt Ratio
Nanjing Well Pharmaceutical Co Ltd (603351) has a Cash Flow-to-Debt Ratio of 0.08x as of September 2025, meaning its operating cash flow of CN¥69.51 Million could theoretically repay 0% of its total liabilities (CN¥819.31 Million) in one year. See free cash flow generation of Nanjing Well Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Nanjing Well Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for Nanjing Well Pharmaceutical Co Ltd across 11 annual periods. Also explore net asset momentum of Nanjing Well Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Nanjing Well Pharmaceutical Co Ltd (2014–2024)
Year-by-year debt coverage analysis for Nanjing Well Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Nanjing Well Pharmaceutical Co Ltd market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.33x | CN¥221.79 Million | CN¥672.72 Million | ▲ +88.2% |
| 2023 | 0.18x | CN¥120.24 Million | CN¥686.22 Million | ▲ +5.4% |
| 2022 | 0.17x | CN¥108.99 Million | CN¥655.76 Million | ▲ +757.0% |
| 2021 | -0.03x | CN¥-11.54 Million | CN¥456.01 Million | ▼ -109.1% |
| 2020 | 0.28x | CN¥93.30 Million | CN¥336.75 Million | ▼ -53.6% |
| 2019 | 0.60x | CN¥129.69 Million | CN¥217.06 Million | ▲ +81.4% |
| 2018 | 0.33x | CN¥63.76 Million | CN¥193.59 Million | ▼ -10.9% |
| 2017 | 0.37x | CN¥71.27 Million | CN¥192.73 Million | ▼ -54.9% |
| 2016 | 0.82x | CN¥128.18 Million | CN¥156.25 Million | ▲ +95.2% |
| 2015 | 0.42x | CN¥81.14 Million | CN¥193.01 Million | ▲ +0.8% |
| 2014 | 0.42x | CN¥74.62 Million | CN¥178.94 Million | — |